Biogen Idec Enters Biosimilars Market via Joint Venture with Samsung Biologics
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 12 (Table of Contents)
Published: 22 Dec-2011
DOI: 10.3833/pdr.v2011.i12.1639 ISSN: 1756-7874
Section: Joint Venture
Fulltext:
Abstract
Samsung Biologics has agreed to establish a US$300 M joint venture with Biogen Idec to develop, manufacture and market biosimilars...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS